These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
60 related articles for article (PubMed ID: 6129185)
1. Effects of somatostatin on established induced ketosis. Fallucca F; Barbetti F; Maldonato A; Spallone V; Giangrande L; Gambardella S Horm Metab Res; 1982 Oct; 14(10):512-5. PubMed ID: 6129185 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of combined insulin and somatostatin infusion for the treatment of experimental diabetic ketoacidosis. Harano Y; Ohgaku S; Hidaka H; Takatsuki K; Shigeta Y Horm Metab Res; 1979 May; 11(5):338-42. PubMed ID: 113327 [No Abstract] [Full Text] [Related]
3. Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. Studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin. Gerich JE; Lorenzi M; Bier DM; Tsalikian E; Schneider V; Karam JH; Forsham PH J Clin Invest; 1976 Apr; 57(4):875-84. PubMed ID: 820717 [TBL] [Abstract][Full Text] [Related]
4. [Metabolic risks of salbutamol in diabetic patients. A study using somatostatin (author's transl)]. Schlienger JL; Compagnie MJ; Dellenbach P; Stephan F Nouv Presse Med; 1980 Sep; 9(32):2247-51. PubMed ID: 6106923 [TBL] [Abstract][Full Text] [Related]
5. Somatostatin and insulin infusion in the management of diabetic ketoacidosis. Greco AV; Ghirlanda G; Altomonte L; Manna R; Rebuzzi AG; Bertoli A Horm Metab Res; 1981 Jun; 13(6):310-4. PubMed ID: 6114915 [TBL] [Abstract][Full Text] [Related]
6. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia. Rizza RA; Cryer PE; Gerich JE J Clin Invest; 1979 Jul; 64(1):62-71. PubMed ID: 36413 [TBL] [Abstract][Full Text] [Related]
7. The antidiabetic action of somatostatin-28 as assessed by the artificial endocrine pancreas: greater potency than somatostatin-14. Hadjidakis DI; Raptis SA; Raptis AE; Karaiskos C; Souvatzoglou A; Diamantopoulos EJ Horm Metab Res; 1987 Nov; 19(11):574-8. PubMed ID: 2892770 [TBL] [Abstract][Full Text] [Related]
8. Metabolic effects of adrenaline and noradrenaline in man: studies with somatostatin. Pernet A; Walker M; Gill GV; Orskov H; Alberti KG; Johnston DG Diabete Metab; 1984 May; 10(2):98-105. PubMed ID: 6146542 [TBL] [Abstract][Full Text] [Related]
9. Differences in metabolic and hormonal milieu in diabetic- and alcohol-induced ketoacidosis. Umpierrez GE; DiGirolamo M; Tuvlin JA; Isaacs SD; Bhoola SM; Kokko JP J Crit Care; 2000 Jun; 15(2):52-9. PubMed ID: 10877365 [TBL] [Abstract][Full Text] [Related]
11. Low-dose intravenous insulin infusion in patients with diabetic ketoacidosis: biochemical effects in children. Lightner ES; Kappy MS; Revsin B Pediatrics; 1977 Nov; 60(5):681-8. PubMed ID: 411105 [TBL] [Abstract][Full Text] [Related]
12. Effect of ketone bodies on glucose production and utilization in the miniature pig. Müller MJ; Paschen U; Seitz HJ J Clin Invest; 1984 Jul; 74(1):249-61. PubMed ID: 6376544 [TBL] [Abstract][Full Text] [Related]
13. Metabolic effects of somatostatin in maturity-onset diabetes. Tamborlane WV; Sherwin RS; Hendler R; Felig P N Engl J Med; 1977 Jul; 297(4):181-3. PubMed ID: 876274 [TBL] [Abstract][Full Text] [Related]
14. The pancreatic glucagon and C-peptide secretion during hyperinsulinemia in euglycemic glucose clamp with or without somatostatin infusion in normal man. Wu MS; Ho LT Horm Metab Res; 1987 Jun; 19(6):253-6. PubMed ID: 2887501 [TBL] [Abstract][Full Text] [Related]
15. Hormone and metabolic profiles in children and adolescents with type I diabetes mellitus. MacGillivray MH; Voorhess ML; Putnam TI; Li PK; Schaefer PA; Bruck E Diabetes Care; 1982; 5 Suppl 1():38-47. PubMed ID: 6821306 [TBL] [Abstract][Full Text] [Related]
16. Hormonal and metabolic effects of somatostatin in diabetic patients submitted to an i.v. arginine infusion. Assan R; Heuclin C; Girard JR; Basdevant A; Predine J; Husson JM Diabete Metab; 1977 Mar; 3(1):11-7. PubMed ID: 870353 [TBL] [Abstract][Full Text] [Related]
17. Long-term treatment of acromegaly with Sandostatin (SMS 201-995). Normalization of most anomalous growth hormone responses. Pieters GF; van Liessum PA; Smals AG; van Gennep JA; Benraad TJ; Kloppenborg PW Acta Endocrinol Suppl (Copenh); 1987; 286():9-18. PubMed ID: 2892339 [TBL] [Abstract][Full Text] [Related]
18. [Role of insulin and counter-regulatory hormones in the metabolic changes caused by insulin deprivation in diabetic patients]. Castillo MJ; Scheen AJ; Gualda P; Lefebvre PJ Rev Esp Fisiol; 1989 Mar; 45(1):53-9. PubMed ID: 2664924 [TBL] [Abstract][Full Text] [Related]
19. Dissociated effects of somatostatin analogs on arginine-induced insulin, glucagon and growth hormone release in acromegalic patients. Wajchenberg BL; Cesar FP; Leme CE; Borghi VC; Souza VC; Souza IT; Neto DG; Germek OA; Coy DH; Comaru-Schally AM Horm Metab Res; 1983 Oct; 15(10):471-4. PubMed ID: 6139329 [TBL] [Abstract][Full Text] [Related]
20. [The effects of somatostatin in acromegaly]. Schaison G; Roger M; Milhaud G Nouv Presse Med; 1976 Mar; 5(10):629-32. PubMed ID: 772591 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]